𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis

✍ Scribed by Michael H. Weisman; Daniel E. Furst; Grace S. Park; Joel M. Kremer; Katie M. Smith; Daniel J. Wallace; Jacques R. Caldwell; Thierry Dervieux


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
89 KB
Volume
54
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacogenomic and metabolic biomarkers
✍ Thierry Dervieux; Neal Greenstein; Joel Kremer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

## Abstract ## Objective To evaluate the contribution of metabolites (methotrexate [MTX] and folate polyglutamate [PG] levels) and pharmacogenetic biomarkers in the folate pathway to the effects of MTX in patients with rheumatoid arthritis not previously treated with this antifolate. ## Methods

Polyglutamation of methotrexate with com
✍ Thierry Dervieux; Daniel Furst; Diana Orentas Lein; Robert Capps; Katie Smith; M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

## Abstract ## Objective Methotrexate (MTX) enters cells through the reduced folate carrier (RFC‐1) and exerts part of its effects through polyglutamation to MTX polyglutamates (MTXPGs) and inhibition of 5‐aminoimidazole‐4‐carboxamide ribonucleotide transformylase (ATIC) and thymidylate synthase (